# OnCo record alliance-a021806 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/alliance-a021806/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "alliance-a021806", "NCT04340141" ;
  schema:name "Alliance A021806"@en ;
  schema:alternateName "A021806"@en, "ALLIANCE A021806"@en ;
  schema:description "Alliance A021806 is the trial the field is waiting for: 358 people with operable pancreatic cancer randomised to surgery first or chemotherapy first with the same total course of modified FOLFIRINOX. It has finished recruiting; the registry gives December 2028 for the primary completion and no results were published in an indexed journal by September 2026."@en ;
  schema:url <https://onco.cc/trials/alliance-a021806/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04340141>, <https://doi.org/10.1245/s10434-024-15817-5> ;
  onco:status "active" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/resectable-pdac/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/folfirinox/> ;
  onco:terms <https://onco.cc/terms/neoadjuvant-adjuvant/>, <https://onco.cc/terms/resectability/>, <https://onco.cc/terms/pancreatic-trials-open-today/> ;
  onco:trials <https://onco.cc/trials/preopanc-3/>, <https://onco.cc/trials/swog-s1505/>, <https://onco.cc/trials/prodige-24/> .